|Bid||3.4895 x 100000|
|Ask||3.5265 x 100000|
|Day's Range||3.3895 - 3.4170|
|52 Week Range||3.0000 - 7.6560|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 22, 2023 - Feb 27, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for GBY.SG
Sangamo Therapeutics ( NASDAQ:SGMO ) Third Quarter 2022 Results Key Financial Results Revenue: US$26.5m (down 7.4% from...
Sangamo (SGMO) delivered earnings and revenue surprises of 2.86% and 2.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
BRISBANE, Calif., November 03, 2022--Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results